Trademark: 79186567
Status Date
Friday, February 9, 2024
Registration Number
5248111
Registration Date
Tuesday, July 25, 2017
Filing Date
Monday, March 7, 2016
Published for Opposition
Tuesday, May 9, 2017
Cancellation Date
Friday, February 9, 2024
5 Diagnostic preparations for medical or veterinary purposes; products, reagents and indicators for medical diagnostics, namely, preparations, reagents and biological indicators for monitoring the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) for medical or veterinary purposes; Diagnostic agents for medical purposes, namely, diagnostic agents for pharmaceutical use; testing materials for medical use, namely, medical diagnostic reagents and assays for testing of body fluids; pharmaceutical and veterinary products, namely, pharmaceutical products for the treatment of Hypercholesterolemia; food supplements for humans or animals; nutraceutical products for therapeutic use and as a dietary supplement, namely, nutraceuticals for the treatment of Hypercholesterolemia and nutraceuticals for use as a dietary supplement; Plasters for medical purposes, namely, material for dressings; disinfectants
44 Medical services; diagnosis of diseases, namely, medical diagnosis of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical diagnostic services, testing and analysis, namely, medical diagnostic testing, monitoring and reporting services; genetic testing for diagnostics or treatments for medical purposes; medical information services provided on the Internet, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical consultation and information services in the field of medical products, namely, providing information relating to diagnostic, prophylactic and treatment of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical, medicinal and pharmaceutical consultation services; medical advisory services; medical information services, namely, providing medical information; medical analyses for the diagnosis and treatment of people, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposes, namely, medical testing relating to the diagnosis and treatment of people; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of samples obtained from patients; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples obtained from patients
10 Surgical, medical, dental and veterinary instruments and apparatus, namely, medical instruments and apparatus for use in a genetic diagnostic kit in the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) procedures; suture materials; instruments and apparatus for medical diagnostics, namely, apparatus for medical diagnostic testing in the fields of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase); automatic analyzers for medical diagnostics, namely, medical diagnostic instruments for the analysis of body fluids; apparatus for diagnostic testing for medical purposes, namely, medical diagnostic apparatus for testing DNA; diagnostic test kits for detecting diseases, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in genetic body fluids testing; apparatus for analyzing DNA in biological samples for medical use; apparatus for collecting samples of body fluids, namely, medical specimen collection devices in the nature of glass slides, cups or bags for the collection of blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in storing blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in collecting blood or saliva samples; Sample preparation device for medical diagnostic uses, namely, sample preparation columns for medical use; containers for medical samples, namely, blood and saliva containers for medical purposes; devices for taking samples for medical use, namely, medical devices for obtaining body fluid samples; urine sample testing instruments for medical diagnostics in the nature of medical diagnostic apparatus for testing DNA; containers specially designed for transporting samples containing living human cells; holders for sample containers, namely, specimen cup holders; capillary tubes for samples
42 Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project study, namely, scientific study and research in the field of the prevention, treatment and management of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical research laboratory services; design and development of apparatus for medical diagnostics; computer-assisted diagnostic testing services, namely, diagnostic services in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; Scientific laboratory services, namely, preparation of biological samples for research purposes; Scientific laboratory services, namely, preparation of biological samples for use in testing and analysis in research laboratories
Feb 9, 2024
Cancelled Section 71
Dec 24, 2022
New Representative At Ib Received
Jul 25, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 9, 2021
New Representative At Ib Received
Dec 18, 2020
Change Of Owner Received From Ib
Nov 20, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 20, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 24, 2017
Final Decision Transaction Processed By Ib
Nov 3, 2017
Final Disposition Notice Sent To Ib
Nov 3, 2017
Final Disposition Processed
Oct 25, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jul 25, 2017
Registered-Principal Register
May 9, 2017
Official Gazette Publication Confirmation E-Mailed
May 9, 2017
Published For Opposition
May 5, 2017
Notification Processed By Ib
Apr 19, 2017
Notification Of Possible Opposition Sent To Ib
Apr 19, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 19, 2017
Notification Of Notice Of Publication E-Mailed
Mar 31, 2017
Law Office Publication Review Completed
Mar 27, 2017
Approved For Pub - Principal Register
Mar 27, 2017
Examiner's Amendment Entered
Mar 27, 2017
Notification Of Examiners Amendment E-Mailed
Mar 27, 2017
Examiners Amendment E-Mailed
Mar 27, 2017
Examiners Amendment -Written
Feb 18, 2017
Teas/Email Correspondence Entered
Feb 18, 2017
Correspondence Received In Law Office
Feb 16, 2017
Assigned To Lie
Feb 6, 2017
Notice Of Revival - E-Mailed
Feb 3, 2017
Teas Response To Office Action Received
Feb 3, 2017
Petition To Revive-Granted
Feb 3, 2017
Teas Petition To Revive Received
Jan 26, 2017
Abandonment Notice Mailed - Failure To Respond
Jan 25, 2017
Abandonment - Failure To Respond Or Late Response
Oct 3, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 3, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 16, 2016
Refusal Processed By Ib
Jun 28, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Jun 28, 2016
Refusal Processed By Mpu
Jun 28, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Jun 27, 2016
Non-Final Action Written
Jun 20, 2016
Assigned To Examiner
May 10, 2016
Application Filing Receipt Mailed
May 6, 2016
New Application Office Supplied Data Entered
May 5, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
